Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Telomere shortening protects against cancer
As time goes by, the tips of your chromosomes – called telomeres–become shorter. This process…
New Research on End-of-Life Care Discussions
New Australian research co-authored by Peter Mac’s Dr Sonia Fullerton shows that most people with…
Genome editing system destroys cancer cells
Researchers at Tel Aviv University (TAU), Israel, have demonstrated that the CRISPR/Cas9 system is very…
SNMMI publishes appropriate use criteria for bone scintigraphy in prostate and breast cancer
The US Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for bone scintigraphy (scans to identify…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.